Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5757571 | 0.85 | CTSS (0.83) | CTSSCTSL | |
| SCHEMBL5762221 | 0.84 | CTSS (0.72) | CTSS | |
| SCHEMBL7788851 | 0.83 | CTSS (0.69) | CTSSCTSL | |
| SCHEMBL5757895 | 0.80 | CTSS (0.82) | CTSS | |
| SCHEMBL6109403 | 0.78 | CTSS (0.83) | CTSSCTSL | |
| SCHEMBL3895945 | 0.75 | CTSS (0.45) | CTSSCTSL | |
| SCHEMBL5375819 | 0.75 | CTSS (0.64) | CTSSCTSL | |
| SCHEMBL5375809 | 0.75 | CTSS (0.64) | CTSSCTSL | |
| SCHEMBL6107671 | 0.74 | CTSS (0.61) | CTSSCTSL | |
| SCHEMBL7788028 | 0.74 | CTSS (0.79) | CTSS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20010041700-A1 | Novel succinate derivative compounds useful as cysteine protease inhibitors | BEKKALI YOUNES (US) | 2001-11-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010041700-A1 | Novel succinate derivative compounds useful as cysteine protease inhibitors | SDHA, LONP1, SUCNR1 | CTSS 15/4885CTSL 56/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.